Institute for Cardiovascular Diseases Dedinje Fractional Flow Reserve (FFR) and Quantitative Flow Ratio (QFR) Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Quantitative Flow Ratio (QFR) has shown good diagnostic performance against Fractional Flow Reserve (FFR) in several meta-analyses, comparable or even superior to nonhyperemic pressure ratios. However, the reproducibility of QFR is modest and there is high inter- and intra-observer variability even when fairly experienced but non-core lab operators (at least 150 QFR procedure experience) are performing the analysis. Although smaller studies have demonstrated that non-core analysis and even paramedical user analysis can have good correlation with FFR, the concern about the diagnostic performance of QFR in real-world clinical practice by inexperienced users remains. The primary objective of Dedinje FFR/QFR Registry is to determine the feasibility and diagnostic performance of QFR analysis by vendor-certified inexperienced medical users in a real-world setting using FFR as the gold standard. All patients \>18 years old who present to the Institute for Cardiovascular Diseases Dedinje and undergo a planned or ad hoc FFR procedure will be asked to participate in the registry. FFR procedure is performed according to the standardized institutional protocol. QFR analysis will be subsequently performed offline according to a standard operating procedure.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \>18 years old

• Had a clinically indicated FFR procedure performed (either as a planned procedure or ad hoc)

Locations
Other Locations
Serbia
Institute for Cardiovascular Diseases Dedinje
RECRUITING
Belgrade
Contact Information
Primary
Natalija Odanovic, MD
natalija.odanovic@gmail.com
+381654732220
Time Frame
Start Date: 2024-10-02
Estimated Completion Date: 2034-10-02
Participants
Target number of participants: 2500
Related Therapeutic Areas
Sponsors
Leads: Institute for Cardiovascular Diseases Dedinje

This content was sourced from clinicaltrials.gov